We are a diverse team of scientists enthusiastic about unravelling the molecular mechanisms of neurodegenerative diseases. At the Dormann lab, we study how RNA-binding proteins, such as TDP-43 and FUS, become dysfunctional in diseases like amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Alzheimer’s disease, for example through aberrant phase separation and aggregation.